FDA clears Worldwide Medical's Ecstasy OTC (over-the-counter) test:
This article was originally published in Clinica
Executive Summary
Worldwide Medical has received US FDA 510(k) clearance to market an on-site test for Ecstasy (MDMA) - the fifth drugs-of-abuse test the firm's over-the-counter (OTC) First Check line. The Lake Forest, California company said that the Ecstasy test is expected to contribute an incremental $1.4m in revenue over the next 52 weeks.